Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Classical hematology 1

Conditions

Breast Neoplasms 3Peripheral Nervous System Diseases 2Urinary Bladder Neoplasms 1Signs and Symptoms 1Sepsis 1Sarcoma 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Neoplasms 1Menstruation Disturbances 1Febrile Neutropenia 1Cross Infection 1Colorectal Neoplasms 1

Interventions

Doxorubicin 13Specimen Handling 12pembrolizumab 11Magnetic Resonance Spectroscopy 10Biopsy 10Cyclophosphamide 9X-Rays 7Ifosfamide 7Radiotherapy 6Phantoms, Imaging 6Gemcitabine 6liposomal doxorubicin 5Nivolumab 5tazemetostat 4palbociclib 4fludarabine 4atezolizumab 4Temozolomide 4Radiation 4Nuclear Medicine Department, Hospital 4Irinotecan 4larotrectinib 3cabozantinib 3Surveys and Questionnaires 3Ipilimumab 3Carboplatin 3Bevacizumab 3ulixertinib 2tipifarnib 2selpercatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Acupuncture Therapy × 90 days × Clear all
NCT06500715 2026-04-29

Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma

Shaare Zedek Medical Center

Phase NA Not yet recruiting
60 enrolled
Classical hematologySarcoma

Cross Infection, Sarcoma, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡